Renaissance Capital logo

MDLS News

Cancer diagnostics company MDNA Life Sciences revises terms ahead of $13 million unit offering

MDLS

MDNA Life Sciences, which is developing genetic tests designed to guide treatment for cancer and endometriosis, revised the terms for its upcoming IPO on Friday. It originally set terms in October 2022 and first revised the offering terms earlier this week. The West Palm Beach, FL-based company now plans to raise $13 million by offering 2.5 million units at a price range of $5 to...read more

Cancer diagnostics company MDNA Life Sciences ups deal size by 29% ahead of $13 million unit offering

MDLS

MDNA Life Sciences, which is developing genetic tests designed to guide treatment for cancer and endometriosis, raised the proposed deal size for its upcoming IPO on Monday. The West Palm Beach, FL-based company now plans to raise $13 million by offering 2.6 million units at a price range of $4.13 to $6.13. The company had most recently filed to offer 2.1 million units at a range...read more

Cancer diagnostics company MDNA Life Sciences sets terms for $11 million IPO

MDLS

MDNA Life Sciences, which is developing genetic tests designed to guide treatment for cancer and endometriosis, announced terms for its IPO on Friday. In its latest filing, the company also disclosed financials for the nine months ended June 30, 2022, and disclosed that it plans to offer shares only. It previously filed to offer units with warrants attached. The West Palm Beach, FL...read more

US IPO Weekly Recap: August Kicks off with a 2 IPO week

MEGL

Two deals priced this week, but only one met the criteria to be included in our 2022 IPO stats. Four new filings, including two offering units, also trickled into the pipeline.  Hong Kong-based Magic Empire Global (MEGL) completed a US offering at its proposed price of $4 to raise $20 million at an $80 million market cap. Doing business as Giraffe Capital,...read more